Multiple Ascending, Sequential, Placebo-controlled, Double-blind Study to Assess Safety, Tolerability and Efficacy of BVS857 in Severe Burn Subjects

Trial Profile

Multiple Ascending, Sequential, Placebo-controlled, Double-blind Study to Assess Safety, Tolerability and Efficacy of BVS857 in Severe Burn Subjects

Discontinued
Phase of Trial: Phase II

Latest Information Update: 11 Mar 2016

At a glance

  • Drugs BVS 857 (Primary)
  • Indications Burns
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 04 Mar 2016 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 15 Apr 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 21 May 2014 Planned End Date changed from 1 Oct 2016 to 1 Sep 2016, as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top